Clinical TrialsSearch results
Number of results: 298
Other
- Randomized Controlled Trial to Evaluate Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatine in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer(JCOG0301, NCSLC-Elderly-CBDCA-RT Phase III)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Outcome study of complete resections for p-N2 non-small cell lung cancer
- non-small cell lung cancer
- JMTO
- 2008-07-28
Other
- Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study.
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-07-23
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- A combination phase II study of paclitaxel and gemcitabine for recurrent or relapsed non-small cell lung cancer previously treated with platinum or docetaxel-based regimen
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-13
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-09
Other
- A Phase II study of Gefitinib as First-Line Treatment for Elderly Patients with Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations.
- Non-Small-Cell Lung Cancer
- Central Japan Lung Study Group
- 2009-04-08